Clinical Trials Sponsored by Sinovac Research and Development Co., Ltd.

Total 138 results

Sinovac Research and Development Co., Ltd.

Not yet recruiting

A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infectious Disease

China
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

COVID-19

China
Sinovac Research and Development Co., Ltd.

Active, not recruiting

Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose

COVID-19

Brazil
Sinovac Research and Development Co., Ltd.

Completed

Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic

COVID-19

Dominican Republic
Sinovac Research and Development Co., Ltd.

Suspended

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

COVID-19

Turkey
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps

China
Sinovac Research and Development Co., Ltd.

Completed

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

COVID-19 | Influenza

China
Sinovac Research and Development Co., Ltd.

Active, not recruiting

Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents

COVID-19

Philippines, Malaysia, Chile, South Africa
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity of an Inactivated COVID-19 Vaccine

COVID-19

China
Sinovac Research and Development Co., Ltd.

Withdrawn

Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above

COVID-19
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults

Covid19

China
Sinovac Research and Development Co., Ltd.

Recruiting

Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above

COVID-19

China
Sinovac Research and Development Co., Ltd.

Recruiting

Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)

COVID-19

China
Sinovac Research and Development Co., Ltd.

Withdrawn

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong

COVID-19

China
Sinovac Research and Development Co., Ltd.

Suspended

Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

COVID-19

China
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children

Influenza

China
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine

Prevention | Pandemic Influenza
Sinovac Biotech Co., Ltd
Jiangxi Center for Disease Control and Prevention

Active, not recruiting

Immunogenicity of After Primary Immunization and Booster Immunization of sIPV

Polio

China
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents

Influenza

China
Shanghai Jiaolian Drug Research and Development...
Shanghai Pharmaceuticals Holding Co., Ltd

Recruiting

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

Primary Membranous Nephropathy

China
Shanghai Jiaolian Drug Research and Development...
Shanghai Pharmaceuticals Holding Co., Ltd

Recruiting

Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

Triple Negative Breast Cancer (TNBC)

China
Sinovac Biotech Co., Ltd
Liaoning Center for Disease Control and Prevention

Active, not recruiting

Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old

Hepatitis A

China
Sinovac Biotech Co., Ltd
Guangdong Center for Disease Prevention and Control

Completed

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

Hand, Foot and Mouth Disease

China
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine

Prevention | Pandemic Influenza | Pandemic Influenza Vaccine

China
Sinovac Biotech Co., Ltd
Shandong Province Centers for Disease Control and Prevention

Completed

Immunogenicity and Safety of Two Different Commercial EV71 Vaccines

Hand, Foot and Mouth Disease

China
Sinovac Biotech Co., Ltd
Shaanxi Provincial Center for Disease Control and Prevention

Completed

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines

Hand, Foot and Mouth Disease

China
Anda Biopharmaceutical Development (Shenzhen) Co...

Recruiting

Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor

Pancreatic Tumor

China
Kyoto Drug Discovery and Development Co., Ltd.

Recruiting

A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arthritic Central Retinal Artery Occlusion (CRAO) (GION)

Central Retinal Artery Occlusion

United States
Taiwan Sunpan Biotechnology Development Co., Ltd.
Virginia Contract Research Organization Co., Ltd.

Completed

To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of TSB-9-W1 in Pre-treated Patients With mCRC. (TSB-9-W1)

Metastatic Colorectal Cancer

Taiwan
Abbott
Rundo International Pharmaceutical Research & Development Co.,Ltd.

Completed

Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas Flow Balanced Anesthesia, Propofol Target Controlled Infusion Anesthesia and Propofol Induction Sevoflurane Maintenance Anesthesia

Elective Laparoscopic Surgery

China
Abbott
Rundo International Pharmaceutical Research & Development Co.,Ltd.

Completed

A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic

Cardiovascular Diseases | Dyslipidemias | Hypertriglyceridemia

China
GlaxoSmithKline
Rundo International Pharmaceutical Research & Development Co.,Ltd.

Completed

Efficacy of Topical Indomethacin Patch Over Placebo in Ankle Sprain Pain Relief

Ankle Sprain

China
Galmed Research and Development, Ltd.

Suspended

A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR) (ARMOR)

Nonalcoholic Steatohepatitis (NASH)

United States
Galmed Research and Development, Ltd.

Enrolling by invitation

Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment

Hepatic Impairment

United States
Abbott
Rundo-Cronova International Pharmaceuticals Research & Development Co., Ltd.

Completed

Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane

Anesthesia, General

China
CardioNavi MedTech (Wuhan) Co., Ltd.
Beijing Jingruitianhe Medical Science and Technology Development Co,Ltd

Recruiting

The StUdy to Evaluate the Performance and safEty of the Novasight HybRid System Using Objective PeRformance Criteria (SUPERIOR)

Coronary Artery Disease

China
Komagome Hospital
Japan Agency for Medical Research and Development; Prism Pharma Co., Ltd.

Completed

A Follow-up Evaluation Study of PRI-724-1101

Hepatitis C Virus-infected Cirrhosis

Japan
Euro CTO Club
NHS Research and Development; Biosensors International; Asahi Intecc Co., Ltd.

Completed

A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions (EuroCTO)

Coronary Occlusion | Dyspnea | Chronic Stable Angina

United Kingdom, Spain, France, Germany, Italy, Latvia
Komagome Hospital
Japan Agency for Medical Research and Development; Prism Pharma Co., Ltd.

Completed

An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis

Hepatitis C Virus-infected Cirrhosis

Japan
Tokyo University
Japan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.

Completed

A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis (DesiReS)

Autoimmune Diseases | Collagen Diseases | Scleroderma, Systemic | Lung Fibrosis | Skin Sclerosis

Japan
Hua Medicine Limited
Shanghai Branch, KunTuo Medical Research and Development (Beijing) Co., Ltd.

Recruiting

A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

Type2diabetes

China
Nagoya University
Japan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.

Completed

The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies (RECIPE)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Japan
Health Products Research and Development Lda.
Blueclinical, Ltd.

Terminated

Effectiveness and Tolerability of LabiaStick#01 in Subjects With Symptomatic Non-hypertrophic Chronic Vulvar Dermatoses

Chronic Disease of Skin

Portugal

Clinical Trials Sponsored by Sinovac Research and Development Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malta

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations